Category: Arch Venture Partners

ARCH Venture Partners raises $1.46 billion across two funds for biotech investing

Against a backdrop where the life-or-death consequences of biotechnology innovation are becoming increasingly apparent as the world races to develop vaccines and therapies to treat COVID-19, life sciences investor ARCH Venture Partners has raised $1.46 billion in funding to finance new tech development. The two funds, ARCH Venture Fund X…

Read More

Aspen Neuroscience raises $70 million for its experimental Parkinson Disease treatment

Since 2012, Dr. Jeanne Loring, the founder of the eponymous Loring Lab at Scripps Research, has been thinking about how to use pluripotent stem cells as a potential treatment for Parkinson Disease. Now, eight years later, Aspen Neuroscience, the company she founded to bring her research to market has raised…

Read More